Royalty Pharma plc

RPRX

$57.77

Name : Royalty Pharma plc

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $33,265,825,792.00

EPSttm : 1.9

Royalty Pharma plc

$57.77

3.57%

$1.99

RPRX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

2.68

Margin Of Safety %

-19

Put/Call OI Ratio

0.19

EPS Next Q Diff

-0.17

EPS Last/This Y

3.33

EPS This/Next Y

0.5

Price

57.76

Target Price

59.57

Analyst Recom

1.44

Performance Q

19.14

Upside

-27.3%

Beta

0.43

Ticker: RPRX

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-06-08	RPRX	54.85	0.15	0.00	13714
2026-06-09	RPRX	55.62	0.15	0.11	13604
2026-06-10	RPRX	54.51	0.15	0.00	13646
2026-06-11	RPRX	55.26	0.15	0.04	13656
2026-06-12	RPRX	54.87	0.15	0.07	13694
2026-06-15	RPRX	54.25	0.15	0.00	13704
2026-06-16	RPRX	54.21	0.15	0.00	13710
2026-06-17	RPRX	53.7	0.15	0.01	13706
2026-06-18	RPRX	52.96	0.15	0.21	13621
2026-06-22	RPRX	53.56	0.23	0.02	9344
2026-06-23	RPRX	55.34	0.22	0.01	9626
2026-06-24	RPRX	54.27	0.22	0.00	9790
2026-06-25	RPRX	54.68	0.22	0.24	9882
2026-06-26	RPRX	56.27	0.22	0.00	9927
2026-06-29	RPRX	57.13	0.19	0.00	11113
2026-06-30	RPRX	56.07	0.19	0.01	11017
2026-07-01	RPRX	55.81	0.19	0.00	10962
2026-07-02	RPRX	57.8	0.19	0.00	10953
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-06-08	RPRX	54.85	11.8	-209.3	5.12
2026-06-09	RPRX	55.64	11.8	-171.7	5.12
2026-06-10	RPRX	54.52	11.8	-211.0	5.12
2026-06-11	RPRX	55.27	11.8	-172.4	5.12
2026-06-12	RPRX	54.87	11.8	-196.5	5.12
2026-06-15	RPRX	54.27	11.8	-200.7	5.12
2026-06-16	RPRX	54.21	11.8	-189.4	5.12
2026-06-17	RPRX	53.69	11.8	-199.1	5.12
2026-06-18	RPRX	52.98	11.8	-203.5	5.12
2026-06-22	RPRX	53.57	11.8	-175.1	5.12
2026-06-23	RPRX	55.35	11.8	-150.2	5.12
2026-06-24	RPRX	54.26	11.8	-210.8	5.12
2026-06-25	RPRX	54.68	11.8	-179.3	5.12
2026-06-26	RPRX	56.25	11.8	-155.2	5.12
2026-06-29	RPRX	57.08	11.8	-171.3	5.12
2026-06-30	RPRX	56.08	11.8	-208.7	5.12
2026-07-01	RPRX	55.78	11.8	-194.1	5.12
2026-07-02	RPRX	57.76	11.8	-147.3	5.12
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-06-08	RPRX	-2.48	-0.35	3.08
2026-06-09	RPRX	-2.48	-0.35	3.08
2026-06-10	RPRX	-2.38	-0.35	2.81
2026-06-11	RPRX	-2.38	-0.35	2.81
2026-06-12	RPRX	-2.38	-0.35	2.81
2026-06-15	RPRX	-2.37	-0.29	2.81
2026-06-16	RPRX	-2.37	-0.29	2.81
2026-06-17	RPRX	-2.37	-0.29	2.81
2026-06-18	RPRX	-2.16	-0.29	2.81
2026-06-22	RPRX	-2.46	-0.18	2.80
2026-06-23	RPRX	-2.62	-0.18	2.80
2026-06-24	RPRX	-2.03	-0.18	2.80
2026-06-25	RPRX	-2.03	-0.18	2.80
2026-06-26	RPRX	-2.44	-0.18	2.69
2026-06-29	RPRX	-2.44	-0.19	2.68
2026-06-30	RPRX	-2.41	-0.19	2.68
2026-07-01	RPRX	-2.41	-0.19	2.68
2026-07-02	RPRX	-2.41	-0.19	2.68
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

1.3

Avg. EPS Est. Current Quarter

1.27

Avg. EPS Est. Next Quarter

1.13

Insider Transactions

-2.41

Institutional Transactions

-0.19

Beta

0.43

Average Sales Estimate Current Quarter

805

Average Sales Estimate Next Quarter

872

Fair Value

46.7

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

-1

Max Drawdown 5-Year %

-42

Target Price

59.57

P/E

30.26

Forward P/E

10.27

PEG

1.12

P/S

13.63

P/B

3.72

P/Free Cash Flow

12.22

EPS

1.91

Average EPS Est. Cur. Y

5.12

EPS Next Y. (Est.)

5.61

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

33.89

Relative Volume

0.87

Return on Equity vs Sector %

-15.6

Return on Equity vs Industry %

1.3

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

-147.3

◆ RPRX Healthcare

$57.77

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

20/20

Pullback

8/25

Volume

7/15

Valuation

4/20

TP/AR

4/10

Options

8/10

RSI

63.9

Range 1M

91.8%

Sup Dist

4.3%

🚀

Momentum Growth

Ride accelerating trends

WATCH

Momentum

23/25

Growth

16/30

Estimates

6/20

Inst/Vol

3/15

Options

8/10

EPS Yr

6.2%

EPS NY

9.6%

52W%

97.8%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +51.7% upside

Quality

6/30

Valuation

14/30

Growth

11/25

Stability

5/10

LT Trend

4/5

Upside

+51.7%

Quality

MoS

-19%

RPRX — P/E HistoricalBiotechnology

Royalty Pharma plc

Sector: Healthcare

Industry: Biotechnology

Employees: 100

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases. The company was founded in 1996 and is based in New York, New York.

RPRX

Latest News

—

Caricamento notizie per RPRX…

stock quote shares RPRX – Royalty Pharma plc Stock Price stock today

news today RPRX – Royalty Pharma plc stock forecast ,stock prediction 2023 2024 2025

marketwatch RPRX – Royalty Pharma plc yahoo finance google finance

stock history RPRX – Royalty Pharma plc invest stock market

stock prices RPRX premarket after hours

ticker RPRX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: RPRX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y